Dr. Kazeem, a highly experienced endocrinologist with over 30 years of clinical practice, has performed nine MWA procedures in recent months. The procedures focused on treating patients with large thyroid nodules, offering a non-surgical alternative.
The clinic reported that these initial MWA procedures have been successfully reimbursed by Medicare. This achievement represents an encouraging early step in supporting broader patient access to the Company's MWA system.
This successful reimbursement in a key U.S. market provides an early indication of the potential for clinical adoption and economic viability of MWA therapy, supporting Baird Medical's mission to broaden access to minimally invasive thyroid treatments.
About Baird Medical
Baird Medical is a forward-thinking medical device company specializing in minimally invasive diagnostics and treatment. It is dedicated to the research and development of surgical robotic systems and innovative minimally invasive surgical instruments. Our mission is to enhance patient outcomes through precision technology and advanced diagnostic solutions. The company will foster strategic collaborations with leading academic institutions. Our vision extends beyond surgical assistance, aiming to develop intelligent systems that proactively guide diagnostic decisions and preventive healthcare strategies. As an FDA 510(k)-certified medical device company, Baird Medical's solutions have been used in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital, Tulane Medical Center, Weill Cornell Medicine, and Columbia University Medical Center. Baird Medical is also the market leader in China in thyroid microwave ablation devices and consumables. Meanwhile, the company's minimally invasive treatment products are gradually expanding their commercial presence in over 20 countries worldwide.
